Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

February 28, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

FluMist

A single dose of either bivalent vaccine or placebo mist by intranasal spray on Study Day 0.

OTHER

Placebo

A single dose of either bivalent vaccine or placebo mist by intranasal spray on Study Day 0

Trial Locations (1)

SFBC International, Inc, Miami